Walvax Biotechnology Co., Ltd.
SZSE:300142.SZ
21.88 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 4,113.772 | 5,086.445 | 3,462.831 | 2,939.021 | 1,121.22 | 879.045 | 668.265 | 591.005 | 1,006.027 | 719.021 | 583.095 | 537.559 | 473.811 | 358.792 | 239.13 | 184.062 | 129.362 |
| Kosten van de omzet
| 750.762 | 609.469 | 394.339 | 399.81 | 227.098 | 172.34 | 215.344 | 280.719 | 574.904 | 406.956 | 161.634 | 63.916 | 41.896 | 32.721 | 32.612 | 38.9 | 63.254 |
| Brutowinst
| 3,363.011 | 4,476.976 | 3,068.492 | 2,539.212 | 894.122 | 706.705 | 452.921 | 310.286 | 431.123 | 312.065 | 421.461 | 473.643 | 431.915 | 326.071 | 206.518 | 145.162 | 66.108 |
| Brutowinstmarge
| 0.818 | 0.88 | 0.886 | 0.864 | 0.797 | 0.804 | 0.678 | 0.525 | 0.429 | 0.434 | 0.723 | 0.881 | 0.912 | 0.909 | 0.864 | 0.789 | 0.511 |
| Onderzoek- en ontwikkelingskosten
| 776.425 | 932.895 | 621.493 | 176.493 | 64.81 | 125.484 | 99.007 | 107.986 | 136.347 | 96.362 | 27.45 | 28.901 | 33.553 | 18.524 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 99.558 | 100.094 | 159.939 | 134.845 | 119.985 | 54.078 | 23.483 | 38.944 | 147.744 | 76.072 | 49.217 | 27.379 | 17.132 | 13.67 | 31.867 | 29.284 | 30.194 |
| Verkoop- en marketingkosten
| 1,474.461 | 2,025.648 | 1,330.989 | 1,130.196 | 499.129 | 349.463 | 253.678 | 150.366 | 208.174 | 187.472 | 104.336 | 122.699 | 144.179 | 91.599 | 61.107 | 70.566 | 26.271 |
| Verkoop-, algemene en administratieve kosten
| 1,868.473 | 2,125.742 | 1,490.929 | 1,265.041 | 619.114 | 403.541 | 277.161 | 189.31 | 355.919 | 263.544 | 153.553 | 150.077 | 161.312 | 105.269 | 92.974 | 99.85 | 56.465 |
| Overige kosten
| 104.146 | 86.585 | 89.581 | 76.315 | 46.014 | -61.78 | -432.506 | 195.412 | 19.172 | 11.807 | 6.833 | -17.576 | -28.755 | 13.578 | 5.093 | 12.276 | 5.014 |
| Bedrijfskosten
| 2,749.044 | 3,145.221 | 2,202.002 | 1,517.849 | 729.938 | 601.686 | 431.804 | 407.119 | 588.587 | 502.221 | 343.988 | 232.484 | 225.216 | 146.84 | 95.234 | 102.435 | 58.51 |
| Bedrijfsresultaat
| 613.966 | 1,099.44 | 967.528 | 1,055.08 | 232.884 | 1,245.279 | -144.154 | -160.357 | -898.165 | 128.161 | 3.508 | 253.894 | 237.977 | 173.417 | 89.167 | 35.164 | 5.549 |
| Bedrijfsresultaat ratio
| 0.149 | 0.216 | 0.279 | 0.359 | 0.208 | 1.417 | -0.216 | -0.271 | -0.893 | 0.178 | 0.006 | 0.472 | 0.502 | 0.483 | 0.373 | 0.191 | 0.043 |
| Totaal overige inkomsten en kosten netto
| -14.99 | -28.975 | -1.33 | 318.224 | -3.423 | 1,042.6 | -432.532 | 175.646 | 13.484 | 15.273 | 6.793 | 13.573 | 7.93 | 9.77 | -9.978 | 8.146 | 3.908 |
| Inkomen voor belasting
| 598.976 | 1,070.465 | 708.945 | 1,373.304 | 229.461 | 1,183.499 | -576.659 | 34.684 | -884.68 | 137.957 | 10.301 | 267.467 | 245.907 | 183.187 | 94.199 | 43.31 | 9.457 |
| Inkomen voor belasting ratio
| 0.146 | 0.21 | 0.205 | 0.467 | 0.205 | 1.346 | -0.863 | 0.059 | -0.879 | 0.192 | 0.018 | 0.498 | 0.519 | 0.511 | 0.394 | 0.235 | 0.073 |
| Belastingkosten
| 87.651 | 132.239 | 107.593 | 162.117 | 35.325 | 120.808 | -18.417 | 4.664 | 39.972 | 41.252 | 5.419 | 42.109 | 38.37 | 28.77 | 17.868 | 8.61 | 2.033 |
| Nettowinst
| 419.39 | 728.652 | 601.352 | 1,003.187 | 194.136 | 1,046.204 | -537.137 | 70.459 | -840.895 | 143.425 | 47.893 | 232.803 | 207.538 | 154.417 | 76.331 | 34.7 | 7.425 |
| Nettowinstmarge
| 0.102 | 0.143 | 0.174 | 0.341 | 0.173 | 1.19 | -0.804 | 0.119 | -0.836 | 0.199 | 0.082 | 0.433 | 0.438 | 0.43 | 0.319 | 0.189 | 0.057 |
| WPA (Winst Per Aandeel)
| 0.26 | 0.46 | 0.38 | 0.65 | 0.13 | 0.68 | -0.35 | 0.05 | -0.6 | 0.1 | 0.033 | 0.17 | 0.15 | 0.14 | 0.073 | 0.055 | 0.079 |
| Verwaterde WPA
| 0.26 | 0.45 | 0.38 | 0.65 | 0.13 | 0.68 | -0.35 | 0.05 | -0.6 | 0.1 | 0.033 | 0.17 | 0.15 | 0.14 | 0.073 | 0.055 | 0.079 |
| EBITDA
| 938.228 | 1,354.904 | 865.899 | 1,503.609 | 341.877 | 1,341.369 | -341.683 | 288.347 | -642.305 | 440.184 | 206.812 | 330.325 | 265.197 | 199.28 | 109.106 | 53.428 | 11.58 |
| EBITDA ratio
| 0.228 | 0.324 | 0.321 | 0.401 | 0.247 | 1.566 | -0.404 | 0.494 | -0.051 | 0.717 | 0.402 | 0.622 | 0.585 | 0.561 | 0.486 | 0.332 | 0.113 |